Abstract
Allergic symptoms usually disturb daily activity of affected subjects. Anti-allergic drug is a specific group of drug designed for allergic symptoms. There are many anti-allergic drugs in use. In addition to oral anti-allergic drugs, there are also non oral anti-allergic drugs. Those forms of anti-allergic drugs are developed expecting for the rapid pharmacological reaction. In this article, the author will briefly review on the patents on non oral anti-allergic drug.
Keywords: Non-oral, anti-allergic drug, patent
Recent Patents on Inflammation & Allergy Drug Discovery
Title: Patenting on Non Oral Anti-Allergic Drug
Volume: 2 Issue: 3
Author(s): Viroj Wiwanitkit
Affiliation:
Keywords: Non-oral, anti-allergic drug, patent
Abstract: Allergic symptoms usually disturb daily activity of affected subjects. Anti-allergic drug is a specific group of drug designed for allergic symptoms. There are many anti-allergic drugs in use. In addition to oral anti-allergic drugs, there are also non oral anti-allergic drugs. Those forms of anti-allergic drugs are developed expecting for the rapid pharmacological reaction. In this article, the author will briefly review on the patents on non oral anti-allergic drug.
Export Options
About this article
Cite this article as:
Wiwanitkit Viroj, Patenting on Non Oral Anti-Allergic Drug, Recent Patents on Inflammation & Allergy Drug Discovery 2008; 2 (3) . https://dx.doi.org/10.2174/187221308786241947
DOI https://dx.doi.org/10.2174/187221308786241947 |
Print ISSN 1872-213X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-2710 |
Related Articles
-
Association of Mutations in the NS5A-PKRBD Region and IFNL4 Genotypes with Hepatitis C Interferon Responsiveness and its Functional and Structural Analysis
Current Proteomics Mechanisms of Improvement of Left Ventricular Function by Intracoronary Human Umbilical Cord-Derived Mesenchymal Stem Cell Infusion in Very Old Patients with Coronary Chronic Total Occlusion
Current Pharmaceutical Design The Two Faces of Interleukin-17A in Atherosclerosis
Current Drug Targets Patent Selections
Recent Patents on Biotechnology Laminin-332-Integrin Interaction: A Target For Cancer Therapy?
Current Medicinal Chemistry Pharmacotherapy and Prevention of Vascular Dementia
CNS & Neurological Disorders - Drug Targets IN MEMORIAM
Endocrine, Metabolic & Immune Disorders - Drug Targets The Effects of Dehydroepiandrosterone (DHEA) in the Treatment of Depression and Depressive Symptoms in Other Psychiatric and Medical Illnesses: A Systematic Review
Current Drug Targets Therapeutic Hypothermia as a Neuroprotective Strategy in Neonatal Hypoxic-Ischemic Brain Injury and Traumatic Brain Injury
Current Molecular Medicine Improved Identification of Cytokines Using Feature Selection Techniques
Letters in Organic Chemistry The Citrus Flavanone Hesperetin Induces Apoptosis in CTCL Cells <i>via</i> STAT3/Notch1/NFκB-Mediated Signaling Axis
Anti-Cancer Agents in Medicinal Chemistry Treatment of Primary Dysmenorrhea Affecting Menstruating Women Using Herbs: A Review
The Natural Products Journal From Erythropoietin to Its Peptide Derivatives: Smaller but Stronger
Current Protein & Peptide Science Targeting the JAK/STAT Signaling Pathway for Breast Cancer
Current Medicinal Chemistry Past, Present and Future Strategies of Immunotherapy in Gynecological Malignancies
Current Molecular Medicine Discovery of Anticoagulant Drugs: A Historical Perspective
Current Drug Discovery Technologies Impact of New Technologies on Pharmacogenomics
Current Pharmacogenomics and Personalized Medicine Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase: New Targets for Future Antidepressants
Current Neuropharmacology Molecular Cloning of Grass Carp Growth Hormone Receptor and Its Functional Interaction with Silver Carp Growth Hormone
Protein & Peptide Letters Follicular Immunology Environment and the Influence on In Vitro Fertilization Outcome
Current Women`s Health Reviews